The structure of a variant HLA-B27 antigen,
Recognition of foreign antigens expressed on the surface of virus-infected or otherwise modified cells by cytolytic T lymphocytes (CTL) is generally carried out in association with shared class I histocompatibility antigens (1) . These are polymorphic cell-surface glycoproteins encoded in the HLA-A, -B, -C loci of the human major histocompatibility complex (MHC) or in the equivalent H-2K, -D, -L regions ofthe mouse genome. They are composed of a MHC-encoded heavy chain, noncovalently bound to /32-microglobulin, an invariant polypeptide (2) . The heavy chain is organized in three extracellular domains designated as al (residues 1-90), a2 (residues 91-182), and a3 (residues 183-275); a transmembrane region; and an intracytoplasmic domain. Variable positions in the extracellular portion are located mainly in al and a2. These domains also carry most of the serological and CTL determinants. By contrast, a3 is much less polymorphic and is probably a major interactive site for 832-microglobulin (3, 4) .
A great knowledge of the structure of class I HLA antigens and of the molecular features of polymorphism has been attained as a result of extensive molecular analyses (5, 6) . However, little is known about the relevance of particular regions of the molecule in determining the specificity of CTL recognition and MHC restriction. A way of approaching this issue takes advantage of the fact that various well-defined serological specificities may be further divided into several subtypes by specific CTL (7) (8) (9) (10) (11) (12) (13) (14) . Detailed biochemical analyses of some of these naturally occurring variants (15) (16) (17) (18) (19) have shown that the different subsets of a given serological specificity differ from each other in a very limited number of amino acid residues. Thus, they provide a unique tool for determining the amino acid sequence substitutions that affect the specificity of CTL recognition.
Although HLA-B27 is one of the best-defined serological specificities (20) , at least three CTL-defined subgroups have been outlined with both allogeneic (11) and virus-immune B27-restricted CTL (12) . These subgroups have been designated as B27W, -K, -C and B27.1, B27.2, and B27.3, respectively. A close correspondence exists between subgroups W and B27.1, K and B27.2, and C and B27.3 (12) . In addition, these subsets may be distinguished on the basis of their differential reactivity with the monoclonal antibody B27M2 (12, 21) . The HLA-B27 antigen is particularly relevant because of its very strong association with ankylosing spondylitis (22) , this association being apparently equal for all B27 subtypes (11) . We have recently determined the amino acid sequence of HLA-B27.1, the major subtype in Caucasians (23) , as well as the structure of an HLA-B27. 3 antigen, a subtype that is predominant in Orientals (19) . In the present report, the structure of the HLA-B27.2 antigen has been determined by comparative peptide mapping with B27.1 and by radiochemical sequence analysis. This study completes the molecular characterization of the three major HLA-B27 functional subtypes and establishes the nature and location of residues of significance in determining the specificity of CTL recognition of this antigen.
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RESULTS
IEF of HLA-B27 from LG-2 and R34. Fig. 1 (24) and probably also to other posttranslational modifications (25) (26) (27) . Neuraminidase treatment did not reduce heterogeneity but resulted in an identical shift of the band patterns of both molecules toward the cathode, as expected from the removal of sialic acid. Thus, the B27.2 molecule is more basic than B27.1 by the equivalent of 1 charge unit.
Compprison of LG-2 and R34 HLA-B27 Heavy Chains by Peptide Mapping. The strategy used for the structural characterization of the HLA-B27.2 molecule was based on its comparison with the B27.1 antigen from LG-2, whose sequence has been determined (23) . Comparative peptide mapping by reverse-phase high-performance liquid chromatography was used because the suitability of this method for the structural analysis of other HLA variants, including HLA-B27.3, is well established (15) (16) (17) (18) (19) .
Initially, leucine-, alanine-, lysine-, and tyrosine-containing tryptic peptide maps were obtained. These amino acids labeled peptides covering 94% of the extracellular portion of HLA-B27. Tyrosine-and lysine-labeled maps were identical (not shown), but both the leucine-and alanine-labeled maps presented a number of difference peaks ( Fig. 2 A and B) . Upon sequence analysis of the difference leucine-labeled peptides (Fig. 3A) , it was shown that both Li and L2 were labeled at step 3, suggesting that they were the B27.1 and Fraction2n.
Fraction n. Fraction n. (Fig. 2C) . A single B27.2 difference peak, 12, was found at the same elution position as L10 and A1O, with no counterpart from B27.1. Its sequence analysis revealed radioactivity at step 1 (Fig. 3A) , confirming the identity of the peptide as that spanning residues 80-83 and the presence of isoleucine at position 80 in B27.2, instead of the threonine residue present in B27.1 (23) .
To determine the nature of the substitution within residues 76-79, a serine-labeled comparative peptide map was first obtained to probe the possibility of a substitution of aspartate-77 in B27.1 (23) to serine, because this residue is frequently found at this position in class I HLA antigens and it was also present in HLA-B27.3 (19, 28) . However, the serine-labeled map revealed no difference peptides other than those due to metabolic conversion of serine to glycine that were also present in a control map of 3H-labeled B27.1 vs.
14C-labeled B27.1 (not shown). The HLA-A24 antigen is the only specificity of known sequence, with no aspartate or serine at position 77. Instead, asparagine is present at this position. Thus, an asparagine-labeled tryptic map was prepared for B27.1 and B27.2 (Fig. 2D) . Two B27.2 difference peaks, N1 and N2, were obtained with no counterpart from B27.1. The elution position of these peaks corresponded with those of L2 and L6, respectively, indicating that N1 was the peptide spanning residues 76-79 and N2 was that spanning residues 71-79. Sequencing of the N1 peptide (Fig. 3A) confirmed the presence of asparagine at position 77 in B27.2, instead of the aspartate-77 present in B27.1. This change accounts for the single-charge difference between these two molecules observed by IEF (Fig. 1) . Finally, glutamine labeling was carried out in the absence of glutamine and glutamate to label both residues, so that the only two peptides not covered by previous maps (those spanning residues 18-21 and 45-48) were labeled. A tryptic map was obtained that completed the mapping of the extracellular portion of the molecule. Only two difference peaks were found: Q5 and Q7 (not shown). They were further purified by ion-exchange chromatography. These peaks corresponded to the B27.1 and B27.2 counterparts, respectively, of peptide 71-79, as assessed by the presence of radioactivity at steps 2 and 6 upon sequencing (Fig. 3A) , corresponding to glutamine-72 and glutamate-76, respectively.
A summary of the assignments given to the various difference peptides, showing the residues directly identified by sequencing, is presented in Fig. 3B (12) . These cells are also lysed by bulk allogeneic CTL specific for subgroup B27K, but not for those that define the W and C subgroups (B. Breur and P. Ivanyi, personal communication). The structural differences between this molecule and the known amino acid sequences of the B27.1 (23) and B27.3 (19) antigens were established by comparative peptide mapping with HLA-B27.1. The only detected changes were aspartate to asparagine at position 77, threonine to isoleucine at position 80, and leucine to alanine at position 81. The possibility that additional substitutions with no effect on the elution profile or that some low-yield difference peptide could have gone undetected cannot be formally excluded. However, it is worth noting that the peptide 152-157, which includes critical residues that are found to vary among most CTL-defined variants (28) , is clearly identified by its elution position (19) as L8, A8 (Fig.  2) , and Q8 (not shown) and is identical between B27.1 and B27.2.
The pattern of amino acid changes between B27.1 and B27.2 provides an example in support of the hypothesis that gene conversion generates polymorphism in the HLA system (30, 31) . All three differences are clustered in a short segment of the sequence. A minimum of three base changes within six consecutive nucleotides is required to account for the two substitutions threonine-80 to isoleucine-80 and leucine-81 to alanine-81. In addition, as mentioned above, all three variable residues 77, 80, and 81 become identical in B27.2 to those in HLA-A24. This is notorious because asparagine-77, isoleucine-80, and alanine-81 are unique in these two proteins when compared with all other class I HLA antigens of known sequence (28) . Because of the nature of these substitutions, B27.2 and A24 become identical between residues 72 and 96. As noted by Nguyen et al. (29) , the coding sequence of the HLA-A24 gene corresponding to residues 75-90 is identical in 46 consecutive nucleotides to that of the pHLA12.4 pseudogene (32) . Since both of these genes were obtained from unrelated libraries, it seems clear that potential donor sequences may exist in an undetermined number of class I genes (or pseudogenes) in the human genome to account for the diversification of B27.1 and B27.2 by a mechanism analogous or identical to gene conversion.
Another example has been recently described for an HLA-A3 variant where the two detected differences with the known sequence of HLA-A3, at positions 152 and 156, make the corresponding region of the sequence identical to HLA-A24 (17) . Thus, as it has been more extensively documented in the mouse (33) (34) (35) , class I antigen variants illustrate the introduction of multiple changes by a single genetic event as a major driving force for the generation of HLA polymorphism and a mechanism with the potential to produce an accelerated diversification of MHC genes.
Interestingly, HLA-B27.2 presents no differences with B27.1 in the segment 147-157, a region that is believed to be critical for CTL recognition (16, 28) . This is the only reported HLA variant defined with polyclonal CTL that has no substitutions in this area. An HLA-B7 variant, CF, has a single detected substitution at residue 116 (18) . However, this variant has been distinguished from other B7 subtypes with cloned CTL but not with bulk effectors. In this respect, HLA-B27.2 is reminiscent of the mouse bm mutants because most of them, except bml (with changes at positions 152, 155, and 156), have their substitutions outside the region 147-157 (36) . Thus, other polymorphic residues, besides those in this segment, determine the specificity of CTL recognition. The HLA-B27.2 antigen is strikingly similar to the bmll mutant in that bmll differs from the parental H-2Kb protein solely at positions 77 and 80 (S. Nathenson, personal communication). This mutant is far from H-2Kb by cellular typing with allospecific CTL (37, 38) . In addition, it is one of the most dissimilar from H-2Kb in its specific inability to function as restriction element for H-2Kb-restricted CTL in a variety of antigenic systems including Sendai virus, minor histocompatibility antigens, and certain haptens (39) (40) (41) . Thus, because of the drastic effect of substitutions within residues 77-81 on CTL recognition in both human and mouse, this segment emerges as another critical portion of the molecule in determining the functional specificity of class I antigens. Studies in the mouse suggest that the functional effect of changes in this area may not be as dramatic as those in the region 147-157. Thus, whereas bml behaves differently from H-2Kb as restriction element for every virus that has been tested, bmll targets are killed by virus-immune H-2Kb_ restricted CTL in some cases, such as with Moloney virus (36) and, to a lower degree, with simian virus 40 (42) . However, an interpretation of these data in terms of the relative importance of segments 77-81 and 147-157 is biased by the possibility that the specific nature of the changes, and not only their location, may significantly influence the functional behavior of the mutants.
The relationship between the specific serological and CTL determinants of HLA-B27 may now be approached by comparing the pattern of substitutions between all three B27.1, B27.2, and B27.3 subgroups and the polymorphic areas of the molecule defined by sequence comparisons. We have previously suggested, on the basis of sequence comparisons with crossreactive specificities, that residues within segments 63-70, 77-83, and 113-116 are major contributors to the HLA-B27 serological allodeterminants (23) . All three B27 subgroups differ in residues within segment 77-81 but are identical in the 63-70 and 113-116 segments (Fig. 4) . This probably accounts for the fact that most conventional alloantisera do not distinguish among B27 subtypes, because many of the residues determining the specific serological determinants remain unchanged. However, some polyclonal alloantisera do distinguish between the CTL subtypes (43) as does the monoclonal antibody B27M2. This antibody reacts with B27.1 and, much more weakly, with B27.3; it is negative with B27.2 (12) . It is now clear that the epitopes recognized by these antibodies include residues within the segment 77-81. Residue 77 is different in all three subtypes and B27.2 has two additional differences. This explains the reactivity pattern of the M2 antibody and the lowest degree of serological relatedness of B27.2.
A number of studies suggest that the bulk of the antibody and CTL responses against class I antigens may be directed against different determinants (refs. 6 and 28 and refs. therein). The fact that the three HLA-B27 subtypes may be Proc. Natl. Acad. Sci. USA 82 (1985) distinguished by both CTL and antibodies and that these subtypes differ from each other in residues within a highly variable region indicates that the epitopes recognized by alloantibodies and CTL are similar to some extent. Further studies are required to properly evaluate this important issue.
It is obvious that other polymorphic regions, in addition to those defined by the limited number of variants that have been characterized, must modulate the specificity of the recognition of HLA antigens by CTL; for example, in spite of the identity of B27.2 and A24 in residues 72-96, the three changes in this region with B27.1 are sufficient for B27.2-specific CTL to abrogate killing of B27.1 targets but not to crossreact with HLA-A24. In addition, HLA-B27 has been suggested to act as a dominant restriction element over other class I antigens in CTL responses against influenza and Epstein-Barr virus, regardless of the B27 subtype (44) . Thus, other polymorphic residues besides those at 77-81 must contribute to the restriction properties of HLA-B27. Clearly, much more work is necessary to unveil the molecular mechanisms of the MHC-restricted antigen recognition by the T-cell receptors. But analyses such as those performed with the HLA-B27 antigens illustrate the value of HLA variants in the definition of functional sites of class I molecules and allow a progressive evaluation of the functional role of HLA polymorphism.
